Skip to main content
logo
Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,365.00
+5.00 (0.21%)
At close: Aug 24, 2026

Korea Arlico Pharm Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-1,625-605.35-5,3583,0618,0344,930
Depreciation & Amortization
4,4734,9326,6154,7723,1132,606
Loss (Gain) From Sale of Assets
58.6958.69-392.92-9.08313.88-964.68
Loss (Gain) From Sale of Investments
-101.68-90.46-240.36-190.71-168.93-30.37
Stock-Based Compensation
-----40.17
Provision & Write-off of Bad Debts
521.84-50.841,390126.29237.65-10.88
Other Operating Activities
689.322,1811,132-1,585984.83889.17
Change in Accounts Receivable
1,3682,421-9,102-2,604-827.32-81.67
Change in Inventory
3,761-337.57-6,475987.01-7,508-2,018
Change in Accounts Payable
-1,111-1,0532,47444.89-305.181,746
Change in Other Net Operating Assets
6,6592,5381,3732,545962.681,861
Operating Cash Flow
14,6939,995-8,5837,1484,8368,967
Operating Cash Flow Growth
---47.80%-46.07%97.25%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2,449-3,112-3,501-23,385-18,974-5,268
Sale of Property, Plant & Equipment
110.73110.731,0299.1145.9543.43
Sale (Purchase) of Intangibles
-1,566-1,886-78.8-135.15-3,434352.82
Investment in Securities
-1,8002,3868,432-3,62213,742-7,737
Other Investing Activities
-105.21-135.21-46.55-117.48-299.486,471
Investing Cash Flow
-5,810-2,6364,834-27,250-8,919-6,137

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-21,68547,89856,1095,7962,826
Long-Term Debt Issued
-7542,00012,99813,633-
Total Debt Issued
32,81022,43949,89869,10719,4292,826
Short-Term Debt Repaid
--22,817-36,738-49,218--
Long-Term Debt Repaid
--2,018-10,776-2,179-342.25-95.02
Total Debt Repaid
-34,649-24,836-47,514-51,398-342.25-95.02
Net Debt Issued (Repaid)
-1,839-2,3962,38417,71019,0872,731
Repurchase of Common Stock
------566.07
Dividends Paid
-2,252-1,126-1,952-1,952-1,051-957.6
Other Financing Activities
---270-19-56.34
Financing Cash Flow
-4,091-3,522162.5315,75818,0551,151

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
17.56-8.494.5415.39-96.2732.47
Net Cash Flow
4,8103,828-3,582-4,32913,8764,013

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
12,2446,883-12,085-16,237-14,1373,699
Free Cash Flow Growth
------
Free Cash Flow Margin
6.15%3.42%-6.35%-8.68%-8.43%2.64%
Free Cash Flow Per Share
812.36458.45-805.18-551.67-936.13245.38
Levered Free Cash Flow
9,6591,909-14,241-19,870-16,7382,647
Unlevered Free Cash Flow
11,0073,256-12,926-18,878-16,1332,820

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1,4131,4651,493807.52599.28278.98
Cash Income Tax Paid
--36.96548.791,565758.081,758
Change in Working Capital
10,6773,570-11,730973.18-7,6781,508